ABBV vs MRK: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Side-by-side fundamentals for AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | ABBV | MRK |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Current Price (Cboe, delayed) | $256.42 | $147.76 |
| Market Cap | $453.12B | $364.55B |
| PE Ratio | 72.23 | 116.35 |
| PEG Ratio | — | 5.57 |
| PEG Verdict | N/A | Potentially Overvalued |